Chargement en cours...

Anticancer activity of NOB1-targeted shRNA combination with TRAIL in epithelial ovarian cancer cells

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) based strategy is a promising targeted therapeutic approach for the treatment of ovarian cancer. However, the effectiveness of the treatment remains limited due to the inherent or acquired resistance of tumor cells to TRAIL. Our previou...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int J Clin Exp Pathol
Auteurs principaux: Lin, Yang, Xu, Tianmin, Teng, Hong, Cui, Manhua
Format: Artigo
Langue:Inglês
Publié: e-Century Publishing Corporation 2015
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4637528/
https://ncbi.nlm.nih.gov/pubmed/26617713
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!